rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2005-9-22
|
pubmed:abstractText |
Cell replacement therapy including the use of embryonic stem cells (ESCs) may represent a novel treatment for damage from stroke. In this study, the authors transplanted neural progenitor cells (NPCs) derived from ESCs into ischemic brain and analyzed their survival and differentiation.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-3085
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
103
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
304-10
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16175861-Animals,
pubmed-meshheading:16175861-Biological Markers,
pubmed-meshheading:16175861-Brain Ischemia,
pubmed-meshheading:16175861-Cell Differentiation,
pubmed-meshheading:16175861-Cell Survival,
pubmed-meshheading:16175861-Green Fluorescent Proteins,
pubmed-meshheading:16175861-Mice,
pubmed-meshheading:16175861-Mice, Inbred C57BL,
pubmed-meshheading:16175861-Neurons,
pubmed-meshheading:16175861-Neurotransmitter Agents,
pubmed-meshheading:16175861-Stem Cell Transplantation
|
pubmed:year |
2005
|
pubmed:articleTitle |
Survival and differentiation of neural progenitor cells derived from embryonic stem cells and transplanted into ischemic brain.
|
pubmed:affiliation |
Department of Neurosurgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. ytakagi@kuhp.kyoto-u.ac.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|